A human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells
- 7 May 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 135 (19) , 1661-1672
Abstract
In human-to-mouse xenogeneic transplantation, polymorphisms of signal-regulatory protein α (SIRPA) that decide their binding affinity for human CD47 are critical for engraftment efficiency of human cells. In the present study, we generated a new C57BL/6.Rag2nullIl2rgnull (BRG) mouse line with Sirpahuman/human (BRGShuman), in which mouse Sirpa was replaced by human SIRPA encompassing all 8 exons. Macrophages in C57BL/6 with Sirpahuman/human had an affinity for human CD47 significantly stronger than those with SirpaNOD/NOD, and did not show detectable phagocytosis against human hematopoietic stem cells. In turn, Sirpahuman/human macrophages had a moderate affinity to mouse CD47, and BRGShuman mice did not show blood cytopenia that was seen in Sirpa-/- mice. In xenotransplantation, BRGShuman mice showed significantly efficient engraftment and maintenance of human hematopoiesis with a high level of myeloid reconstitution, and improved reconstitution in peripheral tissues, as compared to BRG with SirpaNOD/NOD (BRGSNOD) mice. BRGShuman mice also showed significantly enhanced engraftment and growth of acute myeloid leukemia as well as of subcutaneously transplanted human colon cancer cells as compared to those in BRGSNOD mice. The BRGShuman mouse should be a useful basic line in establishing a more faithful xenotransplantation model to study normal and malignant human stem cells.Keywords
This publication has 47 references indexed in Scilit:
- The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implicationsCurrent Opinion in Immunology, 2012
- Transgenic expression of human signal regulatory protein alpha in Rag2−/−γc−/−mice improves engraftment of human hematopoietic cells in humanized miceProceedings of the National Academy of Sciences, 2011
- The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move inJournal of Experimental Medicine, 2011
- Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell nicheJournal of Experimental Medicine, 2011
- Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivoProceedings of the National Academy of Sciences, 2011
- Parameters for establishing humanized mouse models to study human immunity: Analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rγnull mutationClinical Immunology, 2010
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid PhagocytosisCell, 2009
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Non-obese diabetic–recombination activating gene-1 (NOD–Rag 1 null) interleukin (IL)-2 receptor common gamma chain (IL 2 rγnull) null mice: a radioresistant model for human lymphohaematopoietic engraftmentClinical and Experimental Immunology, 2008
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cellsJournal of Cell Biology, 2008